The European Commission has granted marketing authorization for Gilead Sciences’ twice-yearly injection for preventing HIV infection, the company said on Tuesday. Story by Eliza Herbert.
Related Posts
‘As with Maidan and other revolutions in Ukraine, civic mobilisation is an extremely effective tool’
Ukraine has appointed a new head of an economic crimes investigation unit, after rolling back an attempt to overhaul its…
2 trucks busted heading into Ontario from U.S. with 349 kg of cocaine: CBSA
On consecutive days in mid-August, the Canada Border Services Agency say their officers stopped trucks attempting to haul massive quantities…
Veja projetos que enfrentam mudanças climáticas expostos na Bienal de Arquitetura em SP
A Bienal Internacional de Arquitetura de São Paulo chega à 14ª edição neste ano. O evento, que vai até 19…